(Q38025454)

English

The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence

scientific article published on August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Isabella Panaccione

object named as

Isabella Panaccione

10

0 references

14

object named as

Paolo Girardi

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1

object named as

Gabriele Sani

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Giovanni Manfredi

6

object named as

Giovanni Manfredi

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

author name string

Giulia Serra

2

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Giorgio D Kotzalidis

3

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Silvia Romano

4

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Stefano M Tamorri

5

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Matteo Caloro

7

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

C Ludovica Telesforo

8

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Saverio S Caltagirone

9

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Alessio Simonetti

11

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Francesca Demontis

12

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Gino Serra

13

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

663-690

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

https://scigraph.springernature.com/pub.10.2165/11634390-000000000-00000

0 references

Pharmacodynamics of memantine: an update

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine agonist action at dopamine D2High receptors

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine strikes the perfect balance

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine dosing in patients with dementia

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine pharmacotherapy: a naturalistic study using a population pharmacokinetic approach.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Pharmacokinetic study of memantine in healthy and renally impaired subjects

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjects

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease not affected by co-administration of memantine: an open-label, crossover, single-centre study

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The role of dopamine in bipolar disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The role of dopamine in mood disorders

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Role of the mesolimbic dopamine system in the mechanism of action of antidepressants

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Effects of thymoleptics on behavior associated with changes in brain dopamine. II. Modification and potentiation of apomorphine-induced stimulation of mice.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The role of dopamine in the mechanism of action of antidepressant drugs

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Reversal of antidepressant-induced dopaminergic behavioural supersensitivity after long-term chronic imipramine withdrawal.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Long-term imipramine withdrawal induces a depressive-like behaviour in the forced swimming test

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The primacy of mania: a reconsideration of mood disorders

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Mania associated with antidepressant treatment: comprehensive meta-analytic review

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Chronic lithium chloride fails to prevent imipramine-induced sensitization to the dopamine D(2)-like receptor agonist quinpirole.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Carbamazepine prevents imipramine-induced behavioural sensitization to the dopamine D(2)-like receptor agonist quinpirole

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Chronic valproate fails to prevent imipramine-induced behavioural sensitization to the dopamine D2-like receptor agonist quinpirole.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Repeated exposure to methamphetamine, cocaine or morphine induces augmentation of dopamine release in rat mesocorticolimbic slice co-cultures

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Dopaminergic ventral tegmental neurons modulated by methylphenidate

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Sensitization to apomorphine, effects of dizocilpine NMDA receptor blockades

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Expression of behavioral sensitization to ethanol by DBA/2J mice: the role of NMDA and non-NMDA glutamate receptors

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Long-term imipramine effects are prevented by NMDA receptor blockade.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Role of neurotrophic factors in the etiology and treatment of mood disorders

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Course of illness, hippocampal function, and hippocampal volume in major depression

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Hippocampal volume and depression: a meta-analysis of MRI studies

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine reduces mania-like symptoms in animal models.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Management of behavioral problems in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Increased cerebrospinal fluid glutamine levels in depressed patients

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

An open-label, flexible-dose study of memantine in major depressive disorder.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A double-blind, placebo-controlled study of memantine in the treatment of major depression

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Ketamine followed by memantine for the treatment of major depression

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The NMDA receptor hypofunction model of psychosis

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for "NMDA antagonist modelling" of schizophrenia.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Neuropsychological profiles delineate distinct profiles of schizophrenia, an interaction between memory and executive function, and uneven distribution of clinical subtypes

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Neurocognitive allied phenotypes for schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

CNTRICS final task selection: working memory.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Mechanism of action of memantine

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Prestimulus effects on human startle reflex in normals and schizophrenics

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Effects of NMDA receptor ligands on sensorimotor gating in the rat.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents--toward an understanding of their favorable tolerability

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Affinity and specificity of N-methyl- D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The effects of memantine on prepulse inhibition

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Adult neurogenesis in the mammalian central nervous system

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

NMDA receptor regulates migration of newly generated neurons in the adult hippocampus via Disrupted-In-Schizophrenia 1 (DISC1)

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Glutamate as a therapeutic target in psychiatric disorders

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A role for NMDA-receptor channels in working memory.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine and catatonic schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Catatonic schizophrenia and the use of memantine

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Aripiprazole worsening positive symptoms and memantine reducing negative symptoms in a patient with paranoid schizophrenia.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine normalizes brain activity in the inferior frontal gyrus: a controlled pilot fMRI study.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Catatonia: a narrative review.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine and catatonia: a case report and literature review

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The combined effects of memantine and fluoxetine on an animal model of obsessive compulsive disorder.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine for treatment-resistant OCD.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine augmentation for refractory obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine as an augmenting agent for severe pediatric OCD.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Transmitter systems involved in neural plasticity underlying increased anxiety and defense--implications for understanding anxiety following traumatic stress

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Involvement of the NMDA receptor, NO-cyclic GMP and nuclear factor K-beta in an animal model of repeated trauma

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Pilot trial of memantine in the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine for posttraumatic stress disorder in an older veteran

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Pathological gambling: a review of phenomenological models and treatment modalities for an underrecognized psychiatric disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The neurobiology and genetics of impulse control disorders: relationships to drug addictions

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Pathological gambling is linked to reduced activation of the mesolimbic reward system.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

An eight component decision-making model for problem gambling: a systems approach to stimulate integrative research

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Glutamatergic medications for the treatment of drug and behavioral addictions

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Cerebrospinal fluid amino acids in pathological gamblers and healthy controls

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Improvement of pathologic gambling symptoms after administration of sertraline: a case report.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Glutamate and GABA in lateral hypothalamic mechanisms controlling food intake.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

NMDA receptor antagonists potently suppress the spontaneous withdrawal signs induced by discontinuation of long-term diazepam treatment in Fischer 344 rats.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

NMDA receptor function within the anterior piriform cortex and lateral hypothalamus in rats on the control of intake of amino acid-deficient diets

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine reduces consumption of highly palatable food in a rat model of binge eating

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Dual contribution of NR2B subunit of NMDA receptor and SK3 Ca(2+)-activated K+ channel to genetic predisposition to anorexia nervosa.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A new anti-obesity drug treatment: first clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine in the treatment of binge eating disorder: an open-label, prospective trial

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A systematic review of off-label uses of memantine for psychiatric disorders

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Glutamatergic substrates of drug addiction and alcoholism

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Distinctive structural requirement for the binding of uncompetitive blockers (phencyclidine-like drugs) to the NMDA receptor.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Evidence for a role for GABA(A) and NMDA receptors in ethanol inhibition of long-term potentiation

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Acute effects of memantine in combination with alcohol in moderate drinkers.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Alterations in behaviour and glutamate transmission following presentation of stimuli previously associated with cocaine exposure

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Electrical and chemical stimulation of the basolateral complex of the amygdala reinstates cocaine-seeking behavior in the rat.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Relapse to cocaine-seeking after hippocampal theta burst stimulation

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The effects of extinction training in reducing the reinstatement of drug-seeking behavior: involvement of NMDA receptors

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine increases cardiovascular but not behavioral effects of cocaine in methadone-maintained humans

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The effects of acute pretreatment with high-dose memantine on the cardiovascular and behavioral effects of cocaine in humans.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The selective mGlu2/3 receptor antagonist LY341495 exacerbates behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A pilot double-blind treatment trial of memantine for alcohol dependence.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Serotonin transporter polymorphism as a predictor for escitalopram treatment of major depressive disorder comorbid with alcohol dependence.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder -- a magnet resonance spectroscopy study.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder--the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder--lack of effect of methylphenidate

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Effects of NMDA receptor channel blockers, MK-801 and memantine, on locomotor activity and tolerance to delay of reward in Wistar-Kyoto and spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

A pilot evaluation of the safety, tolerability, pharmacokinetics, and effectiveness of memantine in pediatric patients with attention-deficit/hyperactivity disorder combined type

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Glutamate and psychiatric disorders

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Memantine fails to facilitate partial cigarette deprivation in smokers – no role of Memantine in the treatment of nicotine dependency?

1 reference

https://api.crossref.org/works/10.2165%2F11634390-000000000-00000

21 January 2018

Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiepileptic drugs in the control of the impulses disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NMDA, kainate, and AMPA depolarize nondopamine neurons in the rat ventral tegmentum

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The glutamate receptor ion channels

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyposensitivity of dopamine "autoreceptors" induced by chronic administration of tricyclic antidepressants

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Course of the Manic-Depressive Cycle and Changes Caused by Treatments

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid Cyclers and Antidepressants

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Memantine in major depression with catatonic features

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-related production of new granule cells in the adult dentate gyrus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine: involvement of NMDA receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of learning processes by ionotropic glutamate receptor ligands.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

N-methyl-D-aspartic acid biphasically regulates the biochemical and electrophysiological response of A10 dopamine neurons in the ventral tegmental area: in vivo microdialysis and in vitro electrophysiological studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline treatment of pathological gambling: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics and pharmacokinetics of memantine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dizocilpine prevents the enhanced locomotor response to quinpirole induced by repeated electroconvulsive shock

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modification of the startle reflex in the rat by changes in the auditory and visual environments

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excitatory amino acid neurotransmission

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attention deficit induced by blockade of N-methyl D-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: role of metabotropic glutamate receptors 2/3

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly polysialylated neural cell adhesion molecule (NCAM-H) is expressed by newly generated granule cells in the dentate gyrus of the adult rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiology and pathology of NMDA receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amantadine and memantine in catatonic schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum glutamate in depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incipient neurovulnerability and neuroprotection in early psychosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22784018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11634390-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38025454&oldid=1737924278"